CD96 has already been clearly associated with the prognosis of human hepatocellular carcinoma, advanced ovarian cancer, and glioma (Sun et al., 2019; Liu et al., 2020; Maas et al., 2020; Zhang et al., 2020). This evidence concerns the gene CD96 and glioma.